These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 25127378)
1. Quantifying metabolic heterogeneity in head and neck tumors in real time: 2-DG uptake is highest in hypoxic tumor regions. Nakajima EC; Laymon C; Oborski M; Hou W; Wang L; Grandis JR; Ferris RL; Mountz JM; Van Houten B PLoS One; 2014; 9(8):e102452. PubMed ID: 25127378 [TBL] [Abstract][Full Text] [Related]
2. The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma. Wobb J; Krueger SA; Kane JL; Galoforo S; Grills IS; Wilson GD; Marples B Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):820-8. PubMed ID: 26104936 [TBL] [Abstract][Full Text] [Related]
3. Hypoxia, blood flow and metabolism in squamous-cell carcinoma of the head and neck: correlations between multiple immunohistochemical parameters and PET. Grönroos TJ; Lehtiö K; Söderström KO; Kronqvist P; Laine J; Eskola O; Viljanen T; Grénman R; Solin O; Minn H BMC Cancer; 2014 Nov; 14():876. PubMed ID: 25421331 [TBL] [Abstract][Full Text] [Related]
4. Glucose metabolism gene expression patterns and tumor uptake of ¹⁸F-fluorodeoxyglucose after radiation treatment. Wilson GD; Thibodeau BJ; Fortier LE; Pruetz BL; Galoforo S; Baschnagel AM; Chunta J; Oliver Wong CY; Yan D; Marples B; Huang J Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):620-7. PubMed ID: 25304950 [TBL] [Abstract][Full Text] [Related]
5. Pharmacologic activation of tumor hypoxia: a means to increase tumor 2-deoxy-2-[18F]fluoro-D-glucose uptake? Mees G; Dierckx R; Vangestel C; Laukens D; Van Damme N; Van de Wiele C Mol Imaging; 2013; 12(1):49-58. PubMed ID: 23348791 [TBL] [Abstract][Full Text] [Related]
6. High glucose uptake unexpectedly is accompanied by high levels of the mitochondrial ß-F1-ATPase subunit in head and neck squamous cell carcinoma. Huebbers CU; Adam AC; Preuss SF; Schiffer T; Schilder S; Guntinas-Lichius O; Schmidt M; Klussmann JP; Wiesner RJ Oncotarget; 2015 Nov; 6(34):36172-84. PubMed ID: 26452026 [TBL] [Abstract][Full Text] [Related]
7. Hypoxia, metabolism, and growth factor signaling in head and neck squamous cell carcinoma: correlation between primary and xenograft tumors. Stegeman H; Rademakers SE; Span PN; Takes RP; van der Kogel AJ; Kaanders JH; Bussink J Head Neck; 2014 Sep; 36(9):1288-95. PubMed ID: 24668936 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and Bioevaluation of Novel [ Yang X; Wang F; Zhu H; Yang Z; Chu T Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298 [TBL] [Abstract][Full Text] [Related]
9. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors. Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213 [TBL] [Abstract][Full Text] [Related]
10. The reverse Warburg effect and 18F-FDG uptake in non-small cell lung cancer A549 in mice: a pilot study. Zhang G; Li J; Wang X; Ma Y; Yin X; Wang F; Zheng H; Duan X; Postel GC; Li XF J Nucl Med; 2015 Apr; 56(4):607-12. PubMed ID: 25722447 [TBL] [Abstract][Full Text] [Related]
11. Tumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET. Jansen JF; Schöder H; Lee NY; Stambuk HE; Wang Y; Fury MG; Patel SG; Pfister DG; Shah JP; Koutcher JA; Shukla-Dave A Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):299-307. PubMed ID: 21236594 [TBL] [Abstract][Full Text] [Related]
12. Effect of [(18)F]FMISO stratified dose-escalation on local control in FaDu hSCC in nude mice. Schütze C; Bergmann R; Brüchner K; Mosch B; Yaromina A; Zips D; Hessel F; Krause M; Thames H; Kotzerke J; Steinbach J; Baumann M; Beuthien-Baumann B Radiother Oncol; 2014 Apr; 111(1):81-7. PubMed ID: 24636842 [TBL] [Abstract][Full Text] [Related]
13. A prospective clinical study of ¹⁸F-FAZA PET-CT hypoxia imaging in head and neck squamous cell carcinoma before and during radiation therapy. Servagi-Vernat S; Differding S; Hanin FX; Labar D; Bol A; Lee JA; Grégoire V Eur J Nucl Med Mol Imaging; 2014 Aug; 41(8):1544-52. PubMed ID: 24570097 [TBL] [Abstract][Full Text] [Related]
14. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential. Cohen NA; Lai SY; Ziober AF; Ziober BL Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212 [TBL] [Abstract][Full Text] [Related]
15. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model. van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350 [TBL] [Abstract][Full Text] [Related]
16. Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells. Veyrat M; Durand S; Classe M; Glavan TM; Oker N; Kapetanakis NI; Jiang X; Gelin A; Herman P; Casiraghi O; Zagzag D; Enot D; Busson P; Vérillaud B Oncotarget; 2016 Dec; 7(50):82580-82593. PubMed ID: 27791989 [TBL] [Abstract][Full Text] [Related]
17. PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors. Hoeben BA; Kaanders JH; Franssen GM; Troost EG; Rijken PF; Oosterwijk E; van Dongen GA; Oyen WJ; Boerman OC; Bussink J J Nucl Med; 2010 Jul; 51(7):1076-83. PubMed ID: 20554724 [TBL] [Abstract][Full Text] [Related]
18. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Rajendran JG; Mankoff DA; O'Sullivan F; Peterson LM; Schwartz DL; Conrad EU; Spence AM; Muzi M; Farwell DG; Krohn KA Clin Cancer Res; 2004 Apr; 10(7):2245-52. PubMed ID: 15073099 [TBL] [Abstract][Full Text] [Related]
19. Glucose metabolism in NSCLC is histology-specific and diverges the prognostic potential of 18FDG-PET for adenocarcinoma and squamous cell carcinoma. Schuurbiers OC; Meijer TW; Kaanders JH; Looijen-Salamon MG; de Geus-Oei LF; van der Drift MA; van der Heijden EH; Oyen WJ; Visser EP; Span PN; Bussink J J Thorac Oncol; 2014 Oct; 9(10):1485-93. PubMed ID: 25170642 [TBL] [Abstract][Full Text] [Related]
20. Influence of FAZA PET hypoxia and HPV-status for the outcome of head and neck squamous cell carcinoma (HNSCC) treated with radiotherapy: Long-term results from the DAHANCA 24 trial (NCT01017224). Saksø M; Mortensen LS; Primdahl H; Johansen J; Kallehauge J; Hansen CR; Overgaard J Radiother Oncol; 2020 Oct; 151():126-133. PubMed ID: 32805273 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]